Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SAPIEN M3 System Transcatheter Mitral Valve Replacement Via Transseptal Access

NCT04153292 is registered in ClinicalTrials.gov with Edwards Lifesciences as lead sponsor.

NCT NCT04153292
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04153292 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SAPIEN M3 System Transcatheter Mitral Valve Replacement Via Transseptal Access
Lead sponsor
Edwards Lifesciences
Phase
Not applicable
Overall status
Active, not recruiting
Start date
November 12, 2020
Completion date
October 10, 2031
Enrollment
786 (actual)
Sites
54

Conditions

As the registry lists them; a condition with its own page is linked.

mitral regurgitation, mitral valve insufficiency